POST Online Media Lite Edition



 

Sanofi and GSK agree with UK government to supply more than 50 million doses of coronaviris vaccine

Christian Fernsby |
Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply more than 60 million doses of a coronavirus vaccine.

Article continues below



Topics: SANOFI    GSK   

The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein based technology used by Sanofi to produce an influenza vaccine, and GSK’s established pandemic adjuvant technology.


What to read next

Sanofi-Aventis to pay €40.6 million for abusing dominant position
GSK buys 100% of its Indonesian Consumer Healthcare
GlaxoSmithKline fined $490m by China